Why BGPT?
logo

Author Review — inspect what researchers actually reported

Aggregate an author's papers' raw data, methods, conflicts, and reproducibility cues.

Press Enter ↵ to lookup



    Explore by Goal




     Quick Explanation



    Evidence-limited author identity
    “Jin-Sun Jun” is ambiguous in bibliographic databases; the provided OpenAlex match indicates an author profile with ~114 works, ~2502 citations, and h-index ~25, but you did not provide a list of that author’s specific publications to assess scientific contribution directly. I therefore rate scientific strength cautiously and focus on uncertainty/verification priorities rather than paper-level claims.
    Primary bibliometric source: OpenAlex author page for “Jin‐Sun Jun”.



     Long Explanation



    Author Review (Raw-evidence, skeptical): Jin-Sun Jun
    Because the prompt includes only an OpenAlex author-level bibliometric snapshot (no full publication list tied to the specific “Jin-Sun Jun” identity), this review prioritizes what can be supported vs. what is unknown.
    1) Identity ambiguity & what we actually know
    • Database ambiguity: The same or similar name strings can map to multiple different researchers. Your provided search results include several “Jun/Sun/Kim” variants, so verification is needed before any paper-level claims are made.
    • What’s supported from your data: For the OpenAlex entry matching “Jin‐Sun Jun”, the snapshot reports works_count = 114, cited_by_count = 2502, and h_index = 25.
    • What is NOT supported: No provided list of that author’s publications (titles/DOIs) is actually linked to the “Jin‐Sun Jun” identity, so I cannot responsibly attribute any specific mechanistic biology or methods strengths to the author without risking misidentification.
    2) Bibliometric “impact” indicators (weak evidence for scientific quality)
    Bibliometrics can correlate with impact, but they do not prove rigor, novelty, reproducibility, or correct biological inference; they are also sensitive to field size, time window, and citation practices.
    3) Scientific strength: what can/can’t be concluded
    Known from your input (high confidence)
    • The provided OpenAlex entry for “Jin‐Sun Jun” exists and has the bibliometric snapshot cited above.
    Not knowable from your input (therefore not asserted)
    • Subfield expertise: The prompt does not include the author’s publication topics for the exact “Jin‐Sun Jun” record. (You included topic-like fields, but they appear attached to other records in the provided OpenAlex dump.)
    • Methodological rigor: Without the author’s actual papers (DOIs/titles) tied to the correct identity, I cannot evaluate statistical design, controls, blinding, effect sizes, or reproducibility.
    • Accuracy & biological inference: The prompt also includes unrelated extracted data about a cycling-exercise pain-subtype study in early Parkinson’s disease, but it does not state that the author “Jin-Sun Jun” is associated with that study; therefore I do not link it.
    Skeptical conclusion with explicit uncertainty
    Based solely on the bibliometric snapshot, “Jin‐Sun Jun” shows moderate-to-strong citation impact (2502 citations, h-index 25), which is compatible with a productive research record. However, because bibliometrics are weak evidence for rigor and we lack a verified publication list for this specific identity, I cannot claim scientific dominance in any biological domain.
    4) Blind spots / biases to counter (important)
    • Name disambiguation risk: Misattribution is the biggest failure mode here; multiple similar records exist.
    • Citation bias: Older papers accumulate more citations; review/consensus papers often inflate citations; and citation networks can reflect community practices rather than correctness.
    • Publication bias & selective reporting: Bibliometrics cannot reveal whether negative or non-replicating findings were suppressed.
    • Reproducibility & measurement bias: Without paper-level methods and data, there is no way to audit effect-size robustness or confounding control.
    5) Fast path to a genuinely strong author review
    If you provide (a) the author’s top 10–30 paper DOIs/titles for the exact “Jin‐Sun Jun” ID A5085685822, I can evaluate scientific rigor (study design, stats, reproducibility signals) and summarize the most important mechanistic biological contributions with fully verifiable citations.
    (Will attempt to fetch/align the correct Jin‐Sun Jun publication set and perform a rigor-focused synthesis from raw paper content.)


    Feedback:   

    Updated: April 03, 2026

    BGPT Author Review



    Scientific Quality

    40%

    Only an author-level bibliometric snapshot was provided, with no verified publication list tied to the exact “Jin‐Sun Jun” identity. Citation and h-index proxies suggest productivity/impact but cannot establish rigor, mechanism quality, or reproducibility; name ambiguity is a major confounder.



    Communication Quality

    40%

    Communication quality of the author cannot be evaluated without reading their papers’ abstracts/methods/results and presentation style; therefore the score is conservative due to missing content.



    Author Novelty

    40%

    Novelty requires paper-level topic and methodological assessment; with only bibliometrics and no linked works, novelty cannot be responsibly inferred.



    Scientific Rigor

    30%

    Rigor assessment (controls, blinding, statistics, effect sizes, preregistration, data/code availability) is impossible from the provided snapshot; conservative low score due to lack of auditable methods.

     Hypothesis Graveyard



    A high h-index guarantees correct biological conclusions—unlikely, because citation networks reflect many factors beyond truth/rigor, and reproducibility can be uneven across a research portfolio.


    Citation count proves reproducibility—implausible; replication requires method/data transparency, not merely frequent citation.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Follow the Evidence

    New scientific claims, supporting evidence, and important limitations. Every Friday. No ads.


    My BGPT